Literature DB >> 6444967

Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines.

S Gillis, K A Smith, J Watson.   

Abstract

Rat spleen cells activated in vitro by concanavalin A produce lymphokine molecules that possess biologic activity in a number of murine lymphocyte response assays. A single class of lymphokine most adequately described as T cell growth factor (TCGF, Interleukin-2) with a m.w. of 15,000 as estimated from gel filtration studies and with an isoelectric range of 5.4 to 5.6 stimulates i) the growth of established T cell lines in culture, ii) the proliferation of thymocytes in the presence of Con A under culture conditions where Con A alone is non-mitogenic, iii) the induction of antibody responses to heterologous erythrocyte antigens in athymic (nude) mouse spleen cell cultures, and iv) the generation of cytotoxic T lymphocytes (CTL) in thymocyte cultures and in nude mouse spleen cell cultures. We suggest that in each of the assay systems tested, this class of rat lymphokine acts directly on activated T cells. Nonactivated T cells must be stimulated by either mitogen or antigen before becoming responsive to lymphokine, but do not require antigen or mitogen for continued lymphokine-dependent proliferation. Similarly, human peripheral blood mononuclear cells activated by phytohemagglutinin (PHA) produce a class of lymphokines of identical size with an isoelectric point of 6.0 to 6.5 that possess the same biologic properties as measured in murine lymphocyte response systems.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6444967

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  A murine local lymph node assay for the identification of contact allergens. Assay development and results of an initial validation study.

Authors:  I Kimber; C Weisenberger
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

2.  Deficiency of interleukin-2 activity upon addition of soluble egg antigen to cultures of spleen cells from mice infected with Schistosoma japonicum.

Authors:  A B Stavitsky; W W Harold
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

3.  The analysis of an anti-fluorescein response at limit dilution: the effect of lymphokine preparations on the apparent specificity.

Authors:  M A Skinner; R Prestidge; J Marbrook
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

4.  Effect of protein calorie malnutrition on the levels of natural and inducible cytotoxic activities in mouse spleen cells.

Authors:  Q B Saxena; R K Saxena; W H Adler
Journal:  Immunology       Date:  1984-04       Impact factor: 7.397

5.  Effect of feeding a diet with half of the recommended levels of all vitamins on the natural and inducible levels of cytotoxic activity in mouse spleen cells.

Authors:  Q B Saxena; R K Saxena; W H Adler
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

6.  Production and characterization of bovine interleukin-2.

Authors:  A E Namen; J A Magnuson
Journal:  Immunology       Date:  1984-07       Impact factor: 7.397

7.  Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans.

Authors:  S Gillis; R Kozak; M Durante; M E Weksler
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

8.  Purification and initial characterization of rat interleukin 2.

Authors:  G Di Sabato
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

9.  Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.

Authors:  M A Cheever; P D Greenberg; A Fefer; S Gillis
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

10.  Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity.

Authors:  K Welte; C Y Wang; R Mertelsmann; S Venuta; S P Feldman; M A Moore
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.